ÃÛÌÒ´«Ã½

Summary

Sara was educated at the University of Tehran, where she was awarded a Bachelor degree in animal sciences with first class honours in 2008. She moved to the Biosciences Division at ÃÛÌÒ´«Ã½ to undertake her MSc in Molecular Medicine and Cancer Research. In 2011, Sara was awarded a scholarship by the School of Health Sciences and Social Care, ÃÛÌÒ´«Ã½ to investigate Friedreich’s ataxia (FRDA) disease mechanisms using FRDA mouse models and cells under the supervision of Dr Mark Pook. She finished her PhD in 2013 and was awarded Vice Chancellor's best doctoral research prize. She continued her work as a Postdoctoral Research Fellow at ÃÛÌÒ´«Ã½ to study the efficacy and tolerability of histone methyltransferase (HMTase) inhibitors in FRDA. Sara then joined the Institute of Cancer Research (ICR) as a Postdoctoral Research Fellow in 2015 to study the signaling and metabolic networks in breast cancer. In 2018, she was awarded a research grant from Friedreich’s Ataxia Research Alliance (FARA) and joined ÃÛÌÒ´«Ã½ as a Principal Investigator to investigate the metabolic signatures of FRDA. Subsequently, she was appointed as a lecturer in Biosciences. Her research continues to investigate FRDA disease pathogenesis and therapy and identify the most effective therapy for FRDA.

Qualifications

• BSc: Animal Sciences, University of Tehran
• MSc: Molecular Medicine & Cancer Research, ÃÛÌÒ´«Ã½
• PhD: Biomedical Sciences, ÃÛÌÒ´«Ã½
• Postgraduate Certificate in Academic Practice (PgCAP)
• Fellow of Higher Education Academy (FHEA)

Responsibility

• BB5705 – Disease Mechanisms and Therapeutics
• BB5708 – Gene Expression & Epigenetics
• BB3707 – Cellular Pathologies
• BB2712 – Principles of Human Disease
• BB1701 – Module Coordinator - Principles of Anatomy and Physiology
• BB1703 – Research Skills
• BB1806 – Assessment Coordinator